NAD+ / MOTS-C / 5-Amino-1MQ is listed for professional research use with an emphasis on documentation, compound identification, research applications, storage awareness, and third-party testing transparency
Hydroxocobalamin formulation delivers rapid correction of Vitamin B12 deficiency for better energy and growth
No pharmaceutical company has filed an IND application disclosed in the public record
Vitamin B12 injections are generally safe, but some individuals may experience side effects, including: Pain or redness at the injection site Mild diarrhea Itching Nausea or vomiting Dizziness or headaches Hot flashes In rare cases, more serious reactions, such as allergic responses (rash, swelling, trouble breathing), can occur
PE-22-28 Safety Considerations# PE-22-28's safety profile is less burdened by mechanism-specific concerns: TREK-1 channels are expressed throughout the body (brain, heart, vasculature, gastrointestinal tract), so systemic TREK-1 blockade could theoretically affect cardiovascular function, pain sensation, and gastrointestinal motility
